Inhibition of Human Breast Cancer Cell Proliferation by Low-Intensity Ultrasound Stimulation.

Author: Katiyar A1, Osborn J2, DasBanerjee M1, Zhang LG2, Sarkar K2, Sarker KP1
Affiliation:
1Department of Mechanical Engineering, University of Delaware, Newark, Delaware, USA.
2Department of Mechanical and Aerospace Engineering, George Washington University, Washington, DC, USA.
Conference/Journal: J Ultrasound Med.
Date published: 2020 Apr 30
Other: Special Notes: doi: 10.1002/jum.15312. [Epub ahead of print] , Word Count: 239


OBJECTIVES: Cancer is characterized by uncontrolled cell proliferation, which makes novel therapies highly desired. In this study, the effects of near-field low-intensity pulsed ultrasound (LIPUS) stimulation on T47D human breast cancer cell and healthy immortalized MCF-12A breast epithelial cell proliferation were investigated in monolayer cultures.

METHODS: A customized ultrasound (US) exposure setup was used for the variation of key US parameters: intensity, excitation duration, and duty cycle. Cell proliferation was quantified by 5-bromo-2'-deoxyuridine and alamarBlue assays after LIPUS excitation.

RESULTS: At a 20% duty cycle and 10-minute excitation period, we varied LIPUS intensity from to 100 mW/cm2 (spatial-average temporal-average) to find a gradual decrease in T47D cell proliferation, the decrease being strongest at 100 mW/cm2 . In contrast, healthy MCF-12A breast cells showed an increase in proliferation when exposed to the same conditions. Above a 60% duty cycle, T47D cell proliferation decreased drastically. Effects of continuous wave US stimulation were further explored by varying the intensity and excitation period.

CONCLUSIONS: These experiments concluded that, irrespective of the waveform (pulsed or continuous), LIPUS stimulation could inhibit the proliferation of T47D breast cancer cells, whereas the same behavior was not observed in healthy cells. The study demonstrates the beneficial bioeffects of LIPUS on breast cancer cells and offers the possibility of developing novel US-mediated cancer therapy.

© 2020 by the American Institute of Ultrasound in Medicine.

KEYWORDS: T47D; breast cancer; low-intensity pulsed ultrasound; proliferation; therapy

PMID: 32352188 DOI: 10.1002/jum.15312

BACK